Skip to main content
SleepCited

Restless Legs Syndrome: Challenges to Treatment.

Laura M Botta P, Samantha S Anguizola E, Andrea Castro-Villacañas, Diego Garcia-Borreguero
Review Sleep medicine clinics 2021 5 citations

Study Design

Study Type
Review
Intervention
Restless Legs Syndrome: Challenges to Treatment.
Effect Direction
Positive
Risk of Bias
Unclear

Abstract

For a long time, dopaminergic treatment (DT) was the medication for restless legs syndrome. Although DT is effective and safe over the short-term, complications develop over longer periods, including augmentation, tolerance, and impulse control disorders. Nowadays, it is recommended that first-line treatment should be alpha-2 ligands, which are more effective in the absence of previous DT. As a second-line treatment, opioids, such as oxycodone extended-release with naloxone, are approved in Europe. Brain iron should be monitored before and during treatment and corrected if necessary. Two new promising non-DTs are being developed: perampanel and dipyridamole. More research is needed.

TL;DR

First-line treatment for restless legs syndrome should be alpha-2 ligands, which are more effective in the absence of previous DT, and opioids, such as oxycodone extended-release with naloxone, are approved in Europe.

Used In Evidence Reviews

Similar Papers

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.